|Articles|May 24, 2022

MMS Holdings Selects THREAD as Partner

Collaboration will utilize THREAD's DCT technology.

MMS Holdings Inc. (MMS) announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services.

This partnership solidifies MMS as a full-service DCT provider, from electronic data capture (EDC) through completion of the DCT.

Read more about the partnership here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content